Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Pancreatic Neoplasms × Oxaliplatin × Clear all

Phase

Status

Sponsor Class

OTHER 115 INDUSTRY 29 NIH 9 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 10 Colorectal Neoplasms 7 Rectal Neoplasms 4 Neoplasm Metastasis 3 Lung Neoplasms 2 Immunotherapy 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Pancreatic Neoplasms 1 Mid-low Rectal Cancer 1 Locally Advanced Rectal Cancer With Liver Metastases 1 Locally Advanced Rectal Cancer 1 Liver Metastases of Colorectal Cancer 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Colorectal Cancer Liver Metastasis 1 Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction 1 Adenocarcinoma 1

Interventions

Gemcitabine 3 Pancreaticoduodenectomy 2 Erlotinib Hydrochloride 2 olaparib 1 ferric carboxymaltose 1 binimetinib 1 Taxes 1 Surveys and Questionnaires 1 Radiosurgery 1 Radiofrequency Ablation 1 Radiation 1 Propranolol 1 Positron Emission Tomography Computed Tomography 1 Oxaliplatin 1 Nivolumab 1 Ipilimumab 1 Immobilization 1 Etodolac 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Drainage 1 Curcumin 1 Congresses as Topic 1 Celecoxib 1 Capecitabine 1 Analgesia, Patient-Controlled 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00636883 2014-01-22

GEMOX-T

National Guard Health Affairs

Phase 2 Terminated

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡